secwatch.observer — SEC 8-K summary
======================================

Issuer:     TScan Therapeutics, Inc. (TCRX)
CIK:        0001783328
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001193125-26-138973
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TScan Therapeutics VP of Finance resigns; CFO Amello named principal accounting officer
--------------------------------------------------------------------------------

- Leiden Dworak resigns as VP of Finance and principal accounting officer, effective April 10, 2026.
- No disagreements between Dworak and TScan regarding operations, policies, or practices.
- CFO Jason A. Amello appointed as principal accounting officer, effective same date.
- Amello receives no additional compensation for assuming the principal accounting officer role.
- Amello's background is incorporated by reference from TScan's May 2025 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783328/000119312526138973/0001193125-26-138973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783328/000119312526138973/d923169d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-138973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer